R. Coutant

KCNJ11 activating mutations are associated with developmental delay, epilepsy and neonatal diabetes syndrome and other neurological features

Anna L. Gloyn, C. Diatloff‐Zito, Emma L. Edghill et al. · European Journal of Human Genetics · 2006 · 158 citations · Full text

Developmental Biology, Genetic Disorder, Other Neurological Features +9

Hepatocyte Nuclear Factor-1α Gene Inactivation: Cosegregation between Liver Adenomatosis and Diabetes Phenotypes in Two Maturity-Onset Diabetes of the Young (MODY)3 Families

Yves Reznik, Thông Dao, R. Coutant et al. · The Journal of Clinical Endocrinology & Metabolism · 2004 · 135 citations · Full text

Metabolic Syndrome, Hepatology, Diabetes Phenotypes +15

Sensor-augmented pump therapy from the diagnosis of childhood type 1 diabetes: results of the Paediatric Onset Study (ONSET) after 12 months of treatment

Olga Kordonouri, Ewa Pańkowska, Thomas Kapellen et al. · Diabetologia · 2010 · 125 citations · Full text

Sensor-augmented Pump Therapy, Diabetes Management, Diabetes +8

Impaired puberty, fertility, and final stature in 45,X/46,XY mixed gonadal dysgenetic patients raised as boys

Laëtitia Martinerie, Yves Morel, Claire-Lise Gay et al. · European Journal of Endocrinology · 2012 · 115 citations

Only Multiple Autoantibodies to Islet Cells (ICA), Insulin, GAD65, IA-2 and IA-2β Predict Immune-Mediated (Type 1) Diabetes in Relatives

Noel K. Maclaren, Michael S. Lan, R. Coutant et al. · Journal of Autoimmunity · 1999 · 114 citations

Type 1, Autoimmune Disease, Autoantibody Production +12